Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Jasper Therapeutics, Inc. (JSPR : NSDQ)

• Company Description    Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif. Number of Employees: 22

• Price / Volume Information    Yesterday's Closing Price: $0.90 Daily Weekly Monthly 20 Day Moving Average: 233,402 shares Shares Outstanding: 28.00 (millions) Market Capitalization: $25.28 (millions) Beta: 3.07 52 Week High: $7.19 52 Week Low: $0.62 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.23% -5.11% 12 Week -34.09% -39.07% Year To Date -50.66% -56.16%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2200 BRIDGE PKWY SUITE #102 - REDWOOD CITY,CA 94065 USA ph: 650-549-1400 fax: - ir@jaspertherapeutics.com https://jaspertherapeutics.com

• General Corporate Information    Officers Jeet Mahal - President; Chief Executive Officer and Director Thomas G. Wiggans - Chairperson of the Board Herb Cross - Chief Financial Officer Vishal Kapoor - Director Christian W. Nolet - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 471871202 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 28.00 Most Recent Split Date: 1.00 (0.10:1) Beta: 3.07 Market Capitalization: $25.28 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.38 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.80 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.44 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 73.05% vs. Previous Quarter: -18.75% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -613.51 12/31/25 - -372.18 09/30/25 - -261.95 ROA 03/31/26 - -162.52 12/31/25 - -153.67 09/30/25 - -150.80 Current Ratio 03/31/26 - 2.26 12/31/25 - 2.62 09/30/25 - 2.59 Quick Ratio 03/31/26 - 2.26 12/31/25 - 2.62 09/30/25 - 2.59 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 0.12 12/31/25 - 0.15 09/30/25 - 0.41 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©